Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population
Clinical trial NCT00377585 · COMPLETED
Trial details
- NCT number
- NCT00377585
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-22
- Enrollment
- 3350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.